Ann: Alodokter to launch ResAppDx in Indonesia, page-341

Hi piccolo, is it possible that you might have been seen as a company spy...as not being a patient with a cough and asking directly about a product that gives Alodokter a clear advantage over competing telehealth platforms?

It seems strange that a senior Resapphealth manager would state in a public presentation that uses of Resapp dx are "Sky High" and a random contact on the Alodokter chat line states it is under development, to you an unknown person on a chat line inquiring about a very new product.

Maybe if you went through the patient process describing symptoms and complaining of a cough you might have been offered a Resapp dx test and a costing....just a thought..


I have sought clarification...

Thanks piccolo
MB